Experts Discuss Longevity and Durability With Transcatheter Aortic Valve Replacement (TAVR)

Experts Discuss Longevity and Durability With Transcatheter Aortic Valve Replacement (TAVR) is organized by ReachMD.,,Release Date: 09/15/2022,Expiration Date: 09/15/2023,,Overview :,Data are limited on the incidence and factors associated with structural valve deterioration (SVD) after transcatheter aortic valve replacement (TAVR) and surgery for severe aortic stenosis in patients of all risk levels. The lifetime management of these patients requires an understanding of bioprosthetic valve durability and failure. Tune in for new evidence evaluating the 5-year incidence, outcomes, and predictors of hemodynamic SVD in patients undergoing TAVR and surgery that will support best practices for treatment selection.,,Learning Objectives :,After participating in this educational activity, participants should be better able to:,• Evaluate the use of transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) based on recent lifetime management evidence,• Apply recent evidence on structural valve deterioration to validate the clinical use of TAVR in a variety of patient types,• Assess the value of the collaboration between interventional cardiologists and cardiac surgeons, the “heart team approach,” resulting in cooperative and improved care for patients